✨ Education and Health Notices
19 JANUARY 2012 NEW ZEALAND GAZETTE, No. 3 79
Amesbury School, Churton Park, Wellington (614)
Board of Trustees Election Notice
Acting with authority delegated by the Minister of Education under section 101(7) of the Education Act 1989, I approve Monday, 14 May 2012, as the closing date for voting in the first elections of parent representatives and a staff representative for the board of trustees of Amesbury School.
I also approve Monday, 21 May 2012, as the date for the first meeting of the board of trustees.
This notice shall take effect the day after publication.
Dated this 16th day of December 2011.
JEREMY WOOD, Group Manager, Education, Curriculum and Performance.
go281
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Alvesco
Active Ingredient: Ciclesonide 40μg
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Research Associates Limited
Manufacturer: 3M Health Care (UK) Limited, Leicestershire, United Kingdom
Product: Alvesco
Active Ingredient: Ciclesonide 80μg
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Research Associates Limited
Manufacturer: 3M Health Care (UK) Limited, Leicestershire, United Kingdom
Product: Alvesco
Active Ingredient: Ciclesonide 160μg
Dosage Form: Aerosol inhaler, metered dose
New Zealand Sponsor: Research Associates Limited
Manufacturer: 3M Health Care (UK) Limited, Leicestershire, United Kingdom
Dated this 11th day of January 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go228
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Montelukast
Active Ingredient: Montelukast sodium 10.4mg equivalent to Montelukast 10mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Research Private Limited, Bangalore, India
Product: Paracetamol Osteo-Tab
Active Ingredient: Paracetamol 665mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Macleods Pharmaceuticals Limited, Daman, India
Dated this 11th day of January 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go227
Next Page →
✨ LLM interpretation of page content
🎓 Amesbury School Board of Trustees Election Notice
🎓 Education, Culture & Science16 December 2011
Board of Trustees, Election, Amesbury School, Wellington
- JEREMY WOOD, Group Manager, Education, Curriculum and Performance
🏥 Consent to the Distribution of New Medicines (Alvesco)
🏥 Health & Social Welfare11 January 2012
Medicines Act 1981, New Medicines, Alvesco, Ciclesonide
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Consent to the Distribution of New Medicines (Apo-Montelukast and Paracetamol Osteo-Tab)
🏥 Health & Social Welfare11 January 2012
Medicines Act 1981, New Medicines, Apo-Montelukast, Montelukast, Paracetamol Osteo-Tab
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2012, No 3